Yellow Fever Vaccine-Related Neurotropic Disease in Brazil Following Immunization with 17DD.
neurotropic disorder
serious adverse events
vaccine
yellow fever
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
15 Feb 2023
15 Feb 2023
Historique:
received:
04
01
2023
revised:
05
02
2023
accepted:
11
02
2023
entrez:
28
2
2023
pubmed:
1
3
2023
medline:
1
3
2023
Statut:
epublish
Résumé
The disease burden of yellow fever virus infection (YFV) is quite high in the tropics where vaccination coverage is low. To date, vaccination is the most effective control strategy to mitigate and eliminate the burden of YF disease. The licensed YF vaccines are safe and effective and serious adverse events are rare. Herein, we report three cases of neurological syndrome, compatible with meningoencephalitis following 17DD vaccination. In all cases, YFV-specific IgM antibodies were detected in the cerebrospinal fluid. Our observations confirm the development of YF vaccine-associated neurotropic disease, a rare serious adverse event, from which all three patients have fully recovered without any long-term sequelae. This report reinforces the need for awareness among health professionals to recognize and effectively manage such events in a timely manner.
Identifiants
pubmed: 36851322
pii: vaccines11020445
doi: 10.3390/vaccines11020445
pmc: PMC9962731
pii:
doi:
Types de publication
Case Reports
Langues
eng
Subventions
Organisme : NIAID NIH HHS
ID : U01 AI151807
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI151807
Pays : United States
Références
Expert Rev Vaccines. 2018 Jan;17(1):79-90
pubmed: 29172832
Vaccines (Basel). 2022 Apr 30;10(5):
pubmed: 35632466
Clin Vaccine Immunol. 2010 Jan;17(1):118-26
pubmed: 19906894
Yale J Biol Med. 2010 Jun;83(2):77-85
pubmed: 20589188
Neurol Neurochir Pol. 2017 Jan - Feb;51(1):101-105
pubmed: 27707454
J Travel Med. 2020 Nov 9;27(7):
pubmed: 32965473
Rev Med Interne. 1993 Apr;14(4):257-9
pubmed: 8378658
J Med Virol. 2011 Dec;83(12):2208-12
pubmed: 22012730
MMWR Morb Mortal Wkly Rep. 2002 Nov 8;51(44):989-93
pubmed: 12455906
Vaccine. 2004 Jun 2;22(17-18):2103-5
pubmed: 15149765
MMWR Recomm Rep. 2010 Jul 30;59(RR-7):1-27
pubmed: 20671663
Wkly Epidemiol Rec. ;92(16):193-204
pubmed: 28429585
BMJ Case Rep. 2017 Mar 2;2017:
pubmed: 28254833
J Neuroimmunol. 2021 Jun 15;355:577548
pubmed: 33780799
Med Mal Infect. 2009 Apr;39(4):234-41
pubmed: 19167852
Front Neurol. 2022 Feb 18;12:779014
pubmed: 35309283
Hum Vaccin Immunother. 2015;11(9):2183-7
pubmed: 26090855
Pharmaceuticals (Basel). 2021 Sep 01;14(9):
pubmed: 34577591
Vaccines (Basel). 2022 Feb 27;10(3):
pubmed: 35335004
Dtsch Med Wochenschr. 2017 Aug;142(16):1219-1222
pubmed: 28810279
Am J Trop Med Hyg. 2009 Dec;81(6):1141-3
pubmed: 19996449
Vaccine. 2014 Nov 20;32(49):6676-82
pubmed: 24837504
Vaccine. 2013 Apr 3;31(14):1819-29
pubmed: 23395587
Rev Panam Salud Publica. 2018 Jun 05;42:e75
pubmed: 31093103
Vaccine. 2007 Feb 26;25(10):1727-34
pubmed: 17240001
Arch Pediatr. 2014 Apr;21(4):384-7
pubmed: 24630625
J Neurovirol. 2009 Jul;15(4):348-50
pubmed: 19579072
J Travel Med. 2016 Jul 04;23(5):
pubmed: 27378369
BMC Infect Dis. 2020 Feb 10;20(1):116
pubmed: 32041533
Vaccine. 2008 Nov 11;26(48):6077-82
pubmed: 18809449
Lancet. 2001 Jul 14;358(9276):98-104
pubmed: 11463410
Einstein (Sao Paulo). 2020 Feb 17;18:eRC5041
pubmed: 32074223
Vaccine. 2005 May 9;23(25):3256-63
pubmed: 15837230